Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Watson Pharmaceuticals Inc (WPI) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Watson Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 884629.
Total stock buying since 2010: $0.
Total stock sales since 2010: $66,604,540.
Total stock option exercises since 2010: $55,807,196.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2013 | 0 | $0 | 221,889 | $28,944,866 | 820,161 | $37,573,542 |
| 2012 | 0 | $0 | 228,445 | $17,176,638 | 225,955 | $7,470,112 |
| 2011 | 0 | $0 | 199,843 | $12,295,040 | 168,745 | $6,430,360 |
| 2010 | 0 | $0 | 172,019 | $8,187,996 | 129,500 | $4,333,182 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2013-09 | 0 | $0 | 29,013 | $4,011,923 | 232,961 | $19,543,500 |
| 2013-08 | 0 | $0 | 168,963 | $22,823,035 | 579,200 | $17,718,682 |
| 2013-03 | 0 | $0 | 23,913 | $2,109,908 | 8,000 | $311,360 |
| 2012-08 | 0 | $0 | 39,618 | $3,202,494 | 38,250 | $1,170,959 |
| 2012-07 | 0 | $0 | 51,700 | $4,064,246 | 51,700 | $1,844,231 |
| 2012-06 | 0 | $0 | 25,000 | $1,746,100 | 20,000 | $663,750 |
| 2012-05 | 0 | $0 | 107,146 | $7,870,961 | 115,005 | $3,765,532 |
| 2012-02 | 0 | $0 | 4,981 | $292,837 | 1,000 | $25,640 |
| 2011-12 | 0 | $0 | 2,000 | $126,640 | 0 | $0 |
| 2011-11 | 0 | $0 | 10,000 | $657,600 | 10,000 | $368,000 |
| 2011-09 | 0 | $0 | 34,000 | $2,257,710 | 20,000 | $532,000 |
| 2011-08 | 0 | $0 | 33,510 | $2,183,002 | 35,248 | $989,781 |
| 2011-07 | 0 | $0 | 7,202 | $492,688 | 7,500 | $481,350 |
| 2011-06 | 0 | $0 | 2,635 | $169,825 | 0 | $0 |
| 2011-05 | 0 | $0 | 30,018 | $1,903,511 | 19,500 | $720,610 |
| 2011-03 | 0 | $0 | 50,478 | $2,854,664 | 46,497 | $1,884,219 |
| 2011-02 | 0 | $0 | 30,000 | $1,649,400 | 30,000 | $1,454,400 |
| 2010-12 | 0 | $0 | 111,366 | $5,601,574 | 112,500 | $3,849,787 |
| 2010-11 | 0 | $0 | 4,000 | $193,760 | 0 | $0 |
| 2010-08 | 0 | $0 | 29,652 | $1,251,210 | 0 | $0 |
| 2010-06 | 0 | $0 | 27,001 | $1,141,452 | 17,000 | $483,395 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-09-30 | Fridriksdottir Hafrun (Sr VP, Global Generics R&D) | Option Ex | 5,110 | .00 | 0 |
| 2013-09-30 | Eagan Patrick (Chief HR Officer - Global) | Option Ex | 2,851 | .00 | 0 |
| 2013-09-30 | Olafsson Sigurdur O (Pres.-Global Generics) | Option Ex | 150,000 | 86.86 | 13,029,000 |
| 2013-09-30 | Stewart Robert A (Pres-Global Operations) | Option Ex | 75,000 | 86.86 | 6,514,500 |
| 2013-09-16 | Hummel Albert F | Sale | 6,200 | 137.81 | 854,397 |
| 2013-09-04 | Wilkinson George Fred (Pres-Global Brands&Biosimilars) | Sale | 16,749 | 138.00 | 2,311,362 |
| 2013-09-04 | Michelson Jack | Sale | 6,064 | 139.54 | 846,164 |
| 2013-08-29 | Buchen David A (Chief Legal Officer-Global&Sec) | Sale | 10,000 | 135.56 | 1,355,580 |
| 2013-08-29 | Buchen David A (Chief Legal Officer-Global&Sec) | Option Ex | 10,000 | 30.38 | 303,750 |
| 2013-08-26 | Hummel Albert F | Sale | 15,956 | 134.44 | 2,145,140 |
| 2013-08-23 | Hummel Albert F | Sale | 4,044 | 134.16 | 542,551 |
| 2013-08-22 | Hummel Albert F | Sale | 20,000 | 134.50 | 2,689,920 |
| 2013-08-20 | Bisaro Paul (President & CEO) | Sale | 50,000 | 135.30 | 6,765,100 |
| 2013-08-15 | Paonessa Albert Iii (President of Anda, Inc.) | Sale | 5,476 | 135.89 | 744,111 |
| 2013-08-14 | Joyce R Todd (CFO-Global) | Sale | 15,000 | 138.10 | 2,071,500 |
| 2013-08-13 | Hummel Albert F | Sale | 10,000 | 133.85 | 1,338,520 |
| 2013-08-13 | Hummel Albert F | Option Ex | 10,000 | 29.57 | 295,750 |
| 2013-08-12 | Mayr Charles M (Chief Communic Off-Global) | Sale | 4,820 | 133.23 | 642,168 |
| 2013-08-12 | Buchen David A (Chief Legal Officer-Global&Sec) | Sale | 16,800 | 133.01 | 2,234,534 |
| 2013-08-12 | Buchen David A (Chief Legal Officer-Global&Sec) | Option Ex | 16,800 | 26.14 | 439,152 |
| 2013-08-12 | Klema Cathy | Sale | 1,667 | 133.03 | 221,766 |
| 2013-08-09 | Buchen David A (Chief Legal Officer-Global&Sec) | Sale | 200 | 135.00 | 27,000 |
| 2013-08-09 | Buchen David A (Chief Legal Officer-Global&Sec) | Option Ex | 200 | 26.14 | 5,228 |
| 2013-08-09 | Taylor Ronald R | Sale | 5,000 | 135.14 | 675,705 |
| 2013-08-09 | Taylor Ronald R | Option Ex | 5,000 | 29.03 | 145,150 |
| 2013-08-07 | Bisaro Paul (President & CEO) | Option Ex | 527,200 | 30.66 | 16,163,952 |
| 2013-08-05 | Feldman Michel J | Sale | 10,000 | 136.94 | 1,369,440 |
| 2013-08-05 | Feldman Michel J | Option Ex | 10,000 | 36.57 | 365,700 |
| 2013-03-14 | Mayr Charles M (Chief Communic Off-Global) | Sale | 1,000 | 91.77 | 91,770 |
| 2013-03-12 | Buchen David A (Chief Legal Officer-Global&Sec) | Sale | 8,000 | 89.00 | 712,000 |
| 2013-03-12 | Buchen David A (Chief Legal Officer-Global&Sec) | Option Ex | 8,000 | 38.92 | 311,360 |
| 2013-03-12 | Fedida Michael J | Sale | 8,000 | 89.00 | 712,000 |
| 2013-03-05 | Paonessa Albert Iii (President of Anda, Inc.) | Sale | 4,413 | 86.05 | 379,738 |
| 2013-03-04 | Turner Andrew L | Sale | 2,500 | 85.76 | 214,400 |
| 2012-08-30 | Feldman Michel J | Sale | 5,500 | 81.62 | 448,910 |
| 2012-08-24 | Buchen David A (Chief Legal Officer-Global&Sec) | Sale | 24,294 | 81.56 | 1,981,418 |
| 2012-08-24 | Buchen David A (Chief Legal Officer-Global&Sec) | Option Ex | 25,000 | 29.43 | 735,750 |
| 2012-08-01 | Joyce R Todd (CFO-Global & PAO) | Sale | 9,824 | 78.60 | 772,166 |
| 2012-08-01 | Joyce R Todd (CFO-Global & PAO) | Option Ex | 13,250 | 32.85 | 435,209 |
| 2012-07-31 | Klema Cathy | Sale | 21,700 | 78.38 | 1,700,846 |
| 2012-07-31 | Klema Cathy | Option Ex | 21,700 | 34.43 | 747,131 |
| 2012-07-30 | Weiss Fred G | Sale | 30,000 | 78.78 | 2,363,400 |
| 2012-07-30 | Weiss Fred G | Option Ex | 30,000 | 36.57 | 1,097,100 |
| 2012-06-08 | Fedida Michael J | Sale | 5,000 | 70.04 | 350,200 |
| 2012-06-08 | Fedida Michael J | Option Ex | 10,000 | 29.57 | 295,750 |
| 2012-06-07 | Michelson Jack | Sale | 20,000 | 69.80 | 1,395,900 |
| 2012-06-07 | Michelson Jack | Option Ex | 10,000 | 36.80 | 368,000 |
| 2012-05-30 | Taylor Ronald R | Sale | 30,000 | 72.58 | 2,177,400 |
| 2012-05-30 | Taylor Ronald R | Option Ex | 30,000 | 36.80 | 1,104,000 |
| 2012-05-29 | Menard Francois A (SVP,Global Generics R&D) | Sale | 3,467 | 73.89 | 256,176 |
| 2012-05-29 | Hummel Albert F | Sale | 19,000 | 73.74 | 1,401,060 |
| 2012-05-29 | Turner Andrew L | Sale | 20,000 | 73.59 | 1,471,800 |
| 2012-05-29 | Turner Andrew L | Option Ex | 20,000 | 36.80 | 736,000 |
| 2012-05-25 | Joyce R Todd (CFO-Global & PAO) | Option Ex | 5 | 26.40 | 132 |
| 2012-05-25 | Buchen David A (Chief Legal Officer-Global&Sec) | Option Ex | 15,000 | 26.40 | 396,000 |
| 2012-05-08 | Paonessa Albert Iii (President of Anda, Inc.) | Sale | 4,000 | 72.77 | 291,084 |
| 2012-05-07 | Feldman Michel J | Sale | 20,000 | 73.77 | 1,475,400 |
| 2012-05-07 | Feldman Michel J | Option Ex | 20,000 | 36.57 | 731,400 |
| 2012-05-02 | Hummel Albert F | Sale | 10,679 | 74.73 | 798,041 |
| 2012-05-02 | Hummel Albert F | Option Ex | 30,000 | 26.60 | 798,000 |
| 2012-02-29 | Ebert Charles D (Sr. VP, Research & Development) | Sale | 4,981 | 58.79 | 292,837 |
| 2012-02-29 | Ebert Charles D (Sr. VP, Research & Development) | Option Ex | 1,000 | 25.64 | 25,640 |
| 2011-12-02 | Fedida Michael J | Sale | 2,000 | 63.32 | 126,640 |
| 2011-11-15 | Turner Andrew L | Sale | 10,000 | 65.76 | 657,600 |
| 2011-11-15 | Turner Andrew L | Option Ex | 10,000 | 36.80 | 368,000 |
| 2011-09-16 | Hummel Albert F | Sale | 10,000 | 67.25 | 672,510 |
| 2011-09-16 | Fedida Michael J | Option Ex | 20,000 | 26.60 | 532,000 |
| 2011-09-14 | Fedida Michael J | Sale | 20,000 | 66.08 | 1,321,600 |
| 2011-09-14 | Turner Andrew L | Sale | 4,000 | 65.90 | 263,600 |
| 2011-08-29 | Paonessa Albert Iii (EVP & COO of Anda, Inc.) | Sale | 1,517 | 66.19 | 100,417 |
| 2011-08-26 | Buchen David A (Exec VP,General Counsel & Sec.) | Sale | 17,500 | 65.50 | 1,146,250 |
| 2011-08-26 | Buchen David A (Exec VP,General Counsel & Sec.) | Option Ex | 17,500 | 28.15 | 492,625 |
| 2011-08-24 | Joyce R Todd (Exec Vice Pres. & CFO) | Sale | 9,540 | 65.46 | 624,488 |
| 2011-08-24 | Joyce R Todd (Exec Vice Pres. & CFO) | Option Ex | 17,748 | 28.01 | 497,156 |
| 2011-08-15 | Turner Andrew L | Sale | 1,000 | 64.75 | 64,745 |
| 2011-08-05 | Menard Francois A (SVP,Generics R&D) | Sale | 3,953 | 62.51 | 247,102 |
| 2011-07-27 | Joyce R Todd (Exec Vice Pres. & CFO) | Sale | 7,202 | 68.41 | 492,688 |
| 2011-07-27 | Joyce R Todd (Exec Vice Pres. & CFO) | Option Ex | 7,500 | 64.18 | 481,350 |
| 2011-06-01 | Ebert Charles D (Sr. VP, Research & Development) | Sale | 2,635 | 64.45 | 169,825 |
| 2011-05-27 | Buchen David A (Exec VP,General Counsel & Sec.) | Sale | 7,000 | 64.10 | 448,699 |
| 2011-05-27 | Buchen David A (Exec VP,General Counsel & Sec.) | Option Ex | 7,000 | 54.48 | 381,360 |
| 2011-05-06 | Hummel Albert F | Sale | 15,000 | 63.36 | 950,400 |
| 2011-05-04 | Joyce R Todd (Exec Vice Pres. & CFO) | Sale | 8,018 | 62.91 | 504,412 |
| 2011-05-04 | Joyce R Todd (Exec Vice Pres. & CFO) | Option Ex | 12,500 | 27.14 | 339,250 |
| 2011-03-17 | Paonessa Albert Iii (EVP & COO of Anda, Inc.) | Sale | 2,000 | 54.59 | 109,180 |
| 2011-03-10 | Michelson Jack | Sale | 25,000 | 56.42 | 1,410,500 |
| 2011-03-10 | Michelson Jack | Option Ex | 20,000 | 36.80 | 736,000 |
| 2011-03-03 | Joyce R Todd (Sr Vice Pres. & CFO) | Sale | 10,978 | 57.09 | 626,734 |
| 2011-03-03 | Joyce R Todd (Sr Vice Pres. & CFO) | Option Ex | 13,997 | 38.39 | 537,344 |
| 2011-03-03 | Ebert Charles D (Sr. VP, Research & Development) | Sale | 7,500 | 56.36 | 422,700 |
| 2011-03-03 | Ebert Charles D (Sr. VP, Research & Development) | Option Ex | 7,500 | 48.85 | 366,375 |
| 2011-03-03 | Buchen David A (Sr. VP, General Counsel & Sec.) | Sale | 5,000 | 57.11 | 285,550 |
| 2011-03-03 | Buchen David A (Sr. VP, General Counsel & Sec.) | Option Ex | 5,000 | 48.90 | 244,500 |
| 2011-02-23 | Feldman Michel J | Sale | 30,000 | 54.98 | 1,649,400 |
| 2011-02-23 | Feldman Michel J | Option Ex | 30,000 | 48.48 | 1,454,400 |
| 2010-12-16 | Fedida Michael J | Option Ex | 10,000 | 26.60 | 266,000 |
| 2010-12-15 | Russillo Thomas R (EVP, Global Generics) | Sale | 60,000 | 50.00 | 3,000,000 |
| 2010-12-15 | Russillo Thomas R (EVP, Global Generics) | Option Ex | 60,000 | 25.86 | 1,551,600 |
| 2010-12-15 | Fedida Michael J | Sale | 5,227 | 51.07 | 266,963 |
| 2010-12-15 | Weiss Fred G | Sale | 30,000 | 51.03 | 1,530,840 |
| 2010-12-15 | Weiss Fred G | Option Ex | 30,000 | 48.48 | 1,454,400 |
| 2010-12-14 | Joyce R Todd (Sr Vice Pres. & CFO) | Sale | 10,000 | 49.57 | 495,670 |
| 2010-12-14 | Joyce R Todd (Sr Vice Pres. & CFO) | Option Ex | 10,000 | 46.31 | 463,100 |
| 2010-12-10 | Joyce R Todd (Sr Vice Pres. & CFO) | Sale | 2,500 | 49.01 | 122,512 |
| 2010-12-10 | Joyce R Todd (Sr Vice Pres. & CFO) | Option Ex | 2,500 | 45.88 | 114,687 |
| 2010-12-06 | Ebert Charles D (Sr. VP, Research & Development) | Sale | 3,639 | 51.00 | 185,589 |
| 2010-11-29 | Paonessa Albert Iii (EVP & COO of Anda, Inc.) | Sale | 4,000 | 48.44 | 193,760 |
| 2010-08-24 | Hummel Albert F | Sale | 20,000 | 42.07 | 841,420 |
| 2010-08-23 | Feldman Michel J | Sale | 8,334 | 42.48 | 354,011 |
| 2010-08-16 | Carmichael Clare (SR VP, Human Resources) | Sale | 1,318 | 42.32 | 55,779 |
| 2010-06-11 | Turner Andrew L | Sale | 5,000 | 42.58 | 212,900 |
| 2010-06-08 | Michelson Jack | Sale | 22,001 | 42.20 | 928,552 |
| 2010-06-08 | Michelson Jack | Option Ex | 17,000 | 28.43 | 483,395 |
Insider trading activities including stock purchases, stock sales, and option exercises of WPI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Watson Pharmaceuticals Inc (symbol WPI, CIK number 884629) see the Securities and Exchange Commission (SEC) website.